Clinical trial
Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early…
NCT00342303 · National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH · Completed
Key facts
| NCT number | NCT00342303 |
|---|---|
| Title | Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo |
| Official title | Essential Fatty Acid Metabolism in the Newborn: Equivalence of Precusors and Mediators in the Synthesis of Long Chain Polyunsaturated Fatty Acids of the n-6 and n-3 Series |
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Fatty Acid Metabolism |
| Enrollment | 110 |
| Start date | Jun 8, 1993 |
| Completion | Jul 13, 2010 |
| First posted | Jun 21, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | Chile |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: